Shared commitment to improving healthcare access, as Smartway joins Australia-UK roundtable on health emergency preparedness
Smartway Pharmaceuticals is proud to support the Royal Flying Doctor Service, which shares its commitment to overcoming barriers to healthcare. On 12 November 2026, a Smartway team attended the Gala Dinner under the Southern Cross in London, held in support of the Service.
This support closely reflects Smartway's mission of empowering access to medicines globally. Smartway helps hospitals, pharmacies and healthcare providers obtain medicines that are unavailable, unlicensed or difficult to source in their own countries. The Royal Flying Doctor Service uses aviation, medical and communications technology to provide emergency and primary healthcare to people living, working and travelling across rural and remote Australia. Its services include aeromedical retrievals, patient transfers, telehealth consultations and fly-in, fly-out clinics.
For both organisations, geography should not determine whether someone can access the treatment they need.
Commenting, Josh Cocklin, Chief Executive, said:
“Smartway's purpose is to transform lives through access to medicines, wherever patients are located. Our support for the Royal Flying Doctor Service is a natural extension of that purpose. Its teams overcome extraordinary distances to bring healthcare to communities that might otherwise struggle to access it.”
On 11 November 2026, the day before the fundraising gala, Robert Donnell, Executive Vice President, Medicines Access, represented Smartway at a healthcare roundtable hosted by the Australia-UK Chamber of Commerce, with Australia's Chief Medical Officer, Professor Michael Kidd AO, as special guest. The discussion explored how prepared health systems are for future global health emergencies.
Robert Donnell said:
“Attending the roundtable with Australia's Chief Medical Officer, alongside academics, healthcare providers and industry leaders, reinforced the importance of collaboration in tackling healthcare access challenges. Preparedness for global health emergencies brings into focus the risks of medicine shortages and the need for resilient supply chains. When a medicine is unavailable locally, it is often available elsewhere; the task is to source it quickly, safely and through the proper regulatory channels, so that patients can access vital treatments when they need them most. That depends on strong, trusted relationships between government, healthcare providers and industry.”
Australia and New Zealand are strategically important markets for Smartway. The company has supplied healthcare institutions and specialist importers in both countries for many years, buys from the region as well as selling into it, and has an expert team based in the region. It is building on that foundation carefully, supporting healthcare organisations with the compliant supply of medicines that are not locally available and helping address individual patient needs and wider supply challenges.
This approach forms part of Smartway's long-term commitment to the Asia-Pacific region, where the company is strengthening rapidly our existing regulatory and operational capabilityand relationships with hospitals, pharmacies, pharmaceutical companies and other healthcare partners.
Closer to home, the same idea of access sits behind Smartway's three-year partnership with the London Broncos, which aims to expand access to sport across London, including through the Smartway Pharmaceuticals Girls Talent Pathway and free community tickets at every home fixture.
Through its support for the Royal Flying Doctor Service and its developing work across the Asia-Pacific region, Smartway will continue pursuing a simple but important objective: connecting healthcare professionals and patients with medicines that would otherwise be beyond their reach.